Search hospitals > California > San Diego
Ucsd, Avrc Crs
Claim this profileSan Diego, California 92103
Global Leader in Human Immunodeficiency Virus Infection
Global Leader in Infections
Conducts research for Contagious Diseases
Conducts research for Hepatitis C
Conducts research for Hepatitis
127 reported clinical trials
1 medical researcher
Summary
Ucsd, Avrc Crs is a medical facility located in San Diego, California. This center is recognized for care of Human Immunodeficiency Virus Infection, Infections, Contagious Diseases, Hepatitis C, Hepatitis and other specialties. Ucsd, Avrc Crs is involved with conducting 127 clinical trials across 71 conditions. There are 1 research doctors associated with this hospital, such as Susan Little, MD.Area of expertise
1Human Immunodeficiency Virus Infection
Global Leaderalkaline phosphatase
ANC
Hemoglobin
2Infections
Global LeaderTop PIs
Clinical Trials running at Ucsd, Avrc Crs
Human Immunodeficiency Virus Infection
Pre-Exposure Prophylaxis
Obesity
Coronavirus
COVID-19
Multiplex Polymerase Chain Reaction
HIV/AIDS
HIV
Contagious Diseases
HIV Infection
Doravirine
for HIV-Associated Weight Gain
This trial is testing if changing HIV medications to doravirine or switching drug combinations can help patients who have gained weight on their current treatment. The study focuses on people with HIV who have experienced significant weight gain. Doravirine works by blocking a different part of the virus, which might help reduce weight gain and improve overall health. Doravirine is an alternative treatment option for individuals who do not tolerate efavirenz.
Recruiting3 awards Phase 410 criteria
IL-15 Superagonist + Antibodies
for HIV/AIDS
The purpose of this study is to evaluate the safety, tolerability, and efficacy of N-803, an IL-15 superagonist, with or without combination broadly neutralizing antibodies (bNAbs), to induce HIV-1 control during analytic treatment interruption (ATI).
Recruiting1 award Phase 116 criteria
Lenacapavir + F/TDF
for HIV Prevention
The goals of this clinical study are to look at how lenacapavir (LEN) passes through the body and to assess the safety of LEN and emtricitabine/tenofovir disoproxil fumarate (F/TDF) for pre-exposure prophylaxis (PrEP) in people who inject drugs (PWID) in the United States (US). The primary objectives of this study are to characterize the pharmacokinetics (PK) of LEN and to evaluate the safety of LEN and F/TDF for PrEP in US PWID.
Recruiting1 award Phase 27 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Ucsd, Avrc Crs?
Ucsd, Avrc Crs is a medical facility located in San Diego, California. This center is recognized for care of Human Immunodeficiency Virus Infection, Infections, Contagious Diseases, Hepatitis C, Hepatitis and other specialties. Ucsd, Avrc Crs is involved with conducting 127 clinical trials across 71 conditions. There are 1 research doctors associated with this hospital, such as Susan Little, MD.